Screener
Design Therapeutics, Inc. DSGN Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Design Therapeutics, Inc.’s reported figures.
The source filing: Design Therapeutics, Inc.’s 10-Q, filed April 28, 2026. Open the filing →
- Filed
- Apr 28, 2026, 4:13 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-187063
FAQ
- What is Design Therapeutics, Inc.'s free cash flow?
- Design Therapeutics, Inc. (DSGN) reported free cash flow of -$16.43M in Q1 2026.
- How has Design Therapeutics, Inc.'s free cash flow changed year-over-year?
- Design Therapeutics, Inc.'s free cash flow increased by 2.6% year-over-year, from -$16.86M to -$16.43M.
- What is the long-term trend for Design Therapeutics, Inc.'s free cash flow?
- Over 4 years (2021 to 2025), Design Therapeutics, Inc.'s free cash flow has grown at a 15.3% compound annual growth rate (CAGR), from -$30.92M to -$54.55M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Design Therapeutics, Inc.'s free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude